DNA methyltransferase inhibitor CDA-II inhibits myogenic differentiation
Journal Article
·
· Biochemical and Biophysical Research Communications
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou 510060 (China)
- Department of Molecular Genetics and Microbiology, Shands Cancer Center, University of Florida, Gainesville, FL 32610 (United States)
- Department of Hematology, Guangzhou First Municipal People's Hospital, Guangzhou 510180 (China)
Highlights: Black-Right-Pointing-Pointer CDA-II inhibits myogenic differentiation in a dose-dependent manner. Black-Right-Pointing-Pointer CDA-II repressed expression of muscle transcription factors and structural proteins. Black-Right-Pointing-Pointer CDA-II inhibited proliferation and migration of C2C12 myoblasts. -- Abstract: CDA-II (cell differentiation agent II), isolated from healthy human urine, is a DNA methyltransferase inhibitor. Previous studies indicated that CDA-II played important roles in the regulation of cell growth and certain differentiation processes. However, it has not been determined whether CDA-II affects skeletal myogenesis. In this study, we investigated effects of CDA-II treatment on skeletal muscle progenitor cell differentiation, migration and proliferation. We found that CDA-II blocked differentiation of murine myoblasts C2C12 in a dose-dependent manner. CDA-II repressed expression of muscle transcription factors, such as Myogenin and Mef2c, and structural proteins, such as myosin heavy chain (Myh3), light chain (Mylpf) and MCK. Moreover, CDA-II inhibited C1C12 cell migration and proliferation. Thus, our data provide the first evidence that CDA-II inhibits growth and differentiation of muscle progenitor cells, suggesting that the use of CDA-II might affect skeletal muscle functions.
- OSTI ID:
- 22207884
- Journal Information:
- Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 3 Vol. 422; ISSN 0006-291X; ISSN BBRCA9
- Country of Publication:
- United States
- Language:
- English
Similar Records
Histone deacetylase inhibitor trichostatin A enhances myogenesis by coordinating muscle regulatory factors and myogenic repressors
MicroRNA-27a promotes myoblast proliferation by targeting myostatin
CD36 is required for myoblast fusion during myogenic differentiation
Journal Article
·
Fri Nov 04 00:00:00 EDT 2011
· Biochemical and Biophysical Research Communications
·
OSTI ID:22207558
MicroRNA-27a promotes myoblast proliferation by targeting myostatin
Journal Article
·
Fri Jun 29 00:00:00 EDT 2012
· Biochemical and Biophysical Research Communications
·
OSTI ID:22207914
CD36 is required for myoblast fusion during myogenic differentiation
Journal Article
·
Fri Nov 02 00:00:00 EDT 2012
· Biochemical and Biophysical Research Communications
·
OSTI ID:22210314